ATE311907T1 - Anwendung von komplexen von kationischen liposomen und polydeoxyribonukleotiden wie arzneimitteln - Google Patents
Anwendung von komplexen von kationischen liposomen und polydeoxyribonukleotiden wie arzneimittelnInfo
- Publication number
- ATE311907T1 ATE311907T1 AT99111118T AT99111118T ATE311907T1 AT E311907 T1 ATE311907 T1 AT E311907T1 AT 99111118 T AT99111118 T AT 99111118T AT 99111118 T AT99111118 T AT 99111118T AT E311907 T1 ATE311907 T1 AT E311907T1
- Authority
- AT
- Austria
- Prior art keywords
- complexes
- polydeoxyribonucleotides
- cationic liposomes
- drugs
- application
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
- A61K47/6911—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99111118A EP1059092B1 (de) | 1999-06-08 | 1999-06-08 | Anwendung von Komplexen von kationischen Liposomen und Polydeoxyribonukleotiden wie Arzneimitteln |
| US09/330,215 US6767554B2 (en) | 1999-06-08 | 1999-06-11 | Use of complexes among cationic liposomes and polydeoxyribonucleotides and medicaments |
| AU35010/99A AU776014B2 (en) | 1999-06-11 | 1999-06-11 | Use of complexes among cationic liposomes and polydeoxyribonucleotides as medicaments |
| CA002274419A CA2274419A1 (en) | 1999-06-08 | 1999-06-11 | Use of complexes among cationic liposomes and polydeoxyribonucleotides as medicaments |
| KR1019990021947A KR100676492B1 (ko) | 1999-06-08 | 1999-06-12 | 양이온성 리포솜 및 폴리데옥시리보누클레오티드 사이의 복합체의 약제로서의 용도 |
| JP16700999A JP4598908B2 (ja) | 1999-06-08 | 1999-06-14 | カチオン性リポソームとポリデオキシリボヌクレオチドとの複合体 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE311907T1 true ATE311907T1 (de) | 2005-12-15 |
Family
ID=32330163
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99111118T ATE311907T1 (de) | 1999-06-08 | 1999-06-08 | Anwendung von komplexen von kationischen liposomen und polydeoxyribonukleotiden wie arzneimitteln |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6767554B2 (de) |
| EP (1) | EP1059092B1 (de) |
| JP (1) | JP4598908B2 (de) |
| KR (1) | KR100676492B1 (de) |
| AT (1) | ATE311907T1 (de) |
| CA (1) | CA2274419A1 (de) |
| DE (1) | DE69928778T2 (de) |
| DK (1) | DK1059092T3 (de) |
| ES (1) | ES2251134T3 (de) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1332220B1 (de) * | 2000-10-12 | 2008-01-30 | The University of Medicine and Dentistry of New Jersey | Oligonukleotid-unterstützte koaleszenz |
| DK2286795T3 (en) | 2002-06-26 | 2017-02-06 | Syncore Biotechnology Co Ltd | PROCEDURE FOR PREPARING A Cationic LIPOSOMAL PREPARATION INCLUDING A LIPOPHIL COMPOUND |
| JP2006193461A (ja) * | 2005-01-13 | 2006-07-27 | Pola Chem Ind Inc | 毛髪用の洗浄料 |
| ITMI20051303A1 (it) * | 2005-07-08 | 2007-01-09 | Inxel S R L | Metodo per la produzione di vernici in polvere termoindurenti particolarmente per l'applicazione mediante impianti elettrostatici |
| EP1872787A1 (de) * | 2006-06-27 | 2008-01-02 | Gentium S.p.A. | Verwendung von Defibrotide als Heparanasehemmer |
| WO2008093848A1 (ja) * | 2007-02-02 | 2008-08-07 | Sunstar Inc. | ホスファチジルコリンを含有する炎症マーカー低減組成物 |
| EP2103689A1 (de) * | 2008-03-19 | 2009-09-23 | Gentium S.p.A. | Synthetische Phosphodiester-Oligonukleotide und deren therapeutische Verwendungen |
| US20100279353A1 (en) * | 2009-04-30 | 2010-11-04 | Shiu Nan Chen | Process of producing fibrinolytic enzyme from mushroom |
| JP5142295B2 (ja) * | 2009-05-08 | 2013-02-13 | 独立行政法人農業・食品産業技術総合研究機構 | ベシクル及びその製法 |
| WO2010135714A2 (en) | 2009-05-22 | 2010-11-25 | The Methodist Hospital Research Institute | Methods for modulating adipocyte expression using microrna compositions |
| CN107007617A (zh) | 2010-11-12 | 2017-08-04 | 真蒂奥姆责任有限公司 | 去纤维蛋白多核苷酸用于预防和/或治疗移植物抗宿主病(gvhd) |
| GB201204632D0 (en) * | 2012-03-16 | 2012-05-02 | Univ Belfast | Delivery system |
| US9902952B2 (en) | 2012-06-22 | 2018-02-27 | Gentrum S.R.L. | Euglobulin-based method for determining the biological activity of defibrotide |
| US11086970B2 (en) | 2013-03-13 | 2021-08-10 | Blue Belt Technologies, Inc. | Systems and methods for using generic anatomy models in surgical planning |
| KR101534276B1 (ko) * | 2014-07-18 | 2015-07-07 | 주식회사 에스씨301테라피 | 지방 이식 수술 후 지방세포 성장 및 생착 증진을 위한 조성물 |
| EP3026122A1 (de) | 2014-11-27 | 2016-06-01 | Gentium S.p.A. | Zellenbasiertes Verfahren zur Bestimmung der Wirksamkeit von Defibrotid |
| MX2020001337A (es) | 2017-08-03 | 2020-09-09 | Jazz Pharmaceuticals Ireland Ltd | Formulaciones que comprenden un acido nucleico en una alta concentracion. |
| BR112020020865A2 (pt) | 2018-04-12 | 2021-01-19 | Jazz Pharmaceuticals, Inc. | Defibrotida para prevenção e tratamento da síndrome de liberação de citocinas e neurotoxicidade associadas à imunodepleção |
| KR102144615B1 (ko) * | 2018-08-09 | 2020-08-13 | 장건주 | 폴리데옥시리보뉴클레오타이드를 포함하는 마이셀, 약물 전달체 및 이의 제조방법 |
| KR102132478B1 (ko) * | 2018-11-15 | 2020-07-10 | (주)진우바이오 | 히알루론산-폴리데옥시리보뉴클레오타이드 복합체와 이를 활용한 필름 및 이의 제조방법 |
| WO2020118165A1 (en) | 2018-12-07 | 2020-06-11 | Jazz Pharmaceuticals Ireland Limited | Subcutaneous delivery of high concentration formulations |
| CN114727964A (zh) | 2019-09-26 | 2022-07-08 | 日油株式会社 | 脂质纳米粒子的冻干组合物 |
| WO2021174039A1 (en) | 2020-02-28 | 2021-09-02 | Jazz Pharmaceuticals Ireland Limited | Delivery of low viscosity formulations |
| TW202308659A (zh) | 2021-05-06 | 2023-03-01 | 愛爾蘭商爵士製藥愛爾蘭有限責任公司 | 用於急性呼吸窘迫症候群之治療及預防的去纖維蛋白多核苷酸 |
| WO2024106783A1 (ko) * | 2022-11-14 | 2024-05-23 | 주식회사 스템온 | 폴리데옥시리보뉴클레오티드를 포함하는 엑소좀, 이를 포함하는 조성물 및 이의 제조방법 |
| CN115737470A (zh) * | 2022-11-25 | 2023-03-07 | 润辉生物技术（威海）有限公司 | 一种肌肽-pdrn复合物及其制备方法和应用 |
| CN115836982B (zh) * | 2022-12-30 | 2024-02-06 | 南京乐韬生物科技有限公司 | 一种含pdrn的纳米乳液及其制备方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1043823B (it) | 1970-11-03 | 1980-02-29 | Prephar | Procedimento per l estrazione di acidi nucleici da organi animali |
| DE3017154A1 (de) | 1980-05-05 | 1981-11-12 | Hoechst Ag, 6000 Frankfurt | Verfahren zur herstellung von 2-chlor-1,1,1,2,3,3,3,-heptafluor-propan |
| HU192909B (en) * | 1985-01-17 | 1987-07-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing interfuranylene-prostacycline derivatives |
| IT1190313B (it) | 1986-04-17 | 1988-02-16 | Crinos Industria Farmaco | Procedimento per l'ottenimento di polidesossiribonucleotidi chimicamente definiti e riproducibili e prodotto farmacologicamente attivo risultante |
| EP0437479B1 (de) * | 1988-10-05 | 1994-06-22 | Vestar, Inc. | Verfahren zur herstellung von liposomen mit verbesserter stabilität während des trocknens |
| ES2055907T3 (es) * | 1989-03-07 | 1994-09-01 | Genentech Inc | Conjugados covalentes de lipidos y oligonucleotidos. |
| EP0451791A2 (de) * | 1990-04-12 | 1991-10-16 | Hoechst Aktiengesellschaft | Langwirksame Liposomenpräparate von Peptidarzneistoffen und Verfahren zu ihrer Herstellung |
| SG44743A1 (en) | 1991-11-01 | 1997-12-19 | Solvay | Process for the preparation of 1,1,1,2,3,3,3,-heptafluoropropane (R 227) |
| IT1252174B (it) * | 1991-12-09 | 1995-06-05 | Crinos Industria Farmaco | Oligodesossimibonucleotidi ad attivita' antiischemica e procedimenti per il loro ottenimento |
| DE59303465D1 (de) | 1992-03-26 | 1996-09-26 | Hoechst Ag | Verfahren zur Reaktivierung eines bei der Herstellung von 1,1,1,2,3,3,3-Heptafluorpropan (R 227) eingesetzten Aktivkohle-Katalysators |
| US5395619A (en) * | 1993-03-03 | 1995-03-07 | Liposome Technology, Inc. | Lipid-polymer conjugates and liposomes |
| DE4323054A1 (de) | 1993-07-14 | 1995-01-19 | Hoechst Ag | Verfahren zur Herstellung von 2-H-Heptafluorpropan |
| US6071890A (en) * | 1994-12-09 | 2000-06-06 | Genzyme Corporation | Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy |
| US5908777A (en) * | 1995-06-23 | 1999-06-01 | University Of Pittsburgh | Lipidic vector for nucleic acid delivery |
| JPH11511128A (ja) * | 1995-08-01 | 1999-09-28 | ノバルティス・アクチエンゲゼルシャフト | リポソームオリゴヌクレオチド組成物 |
| US5837283A (en) * | 1997-03-12 | 1998-11-17 | The Regents Of The University Of California | Cationic lipid compositions targeting angiogenic endothelial cells |
-
1999
- 1999-06-08 DE DE69928778T patent/DE69928778T2/de not_active Expired - Lifetime
- 1999-06-08 DK DK99111118T patent/DK1059092T3/da active
- 1999-06-08 EP EP99111118A patent/EP1059092B1/de not_active Expired - Lifetime
- 1999-06-08 AT AT99111118T patent/ATE311907T1/de active
- 1999-06-08 ES ES99111118T patent/ES2251134T3/es not_active Expired - Lifetime
- 1999-06-11 US US09/330,215 patent/US6767554B2/en not_active Expired - Lifetime
- 1999-06-11 CA CA002274419A patent/CA2274419A1/en not_active Abandoned
- 1999-06-12 KR KR1019990021947A patent/KR100676492B1/ko not_active IP Right Cessation
- 1999-06-14 JP JP16700999A patent/JP4598908B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1059092B1 (de) | 2005-12-07 |
| DK1059092T3 (da) | 2006-03-27 |
| EP1059092A1 (de) | 2000-12-13 |
| US20020142029A1 (en) | 2002-10-03 |
| JP4598908B2 (ja) | 2010-12-15 |
| DE69928778T2 (de) | 2006-07-06 |
| CA2274419A1 (en) | 2000-12-11 |
| KR100676492B1 (ko) | 2007-01-30 |
| ES2251134T3 (es) | 2006-04-16 |
| DE69928778D1 (de) | 2006-01-12 |
| KR20010002244A (ko) | 2001-01-15 |
| US6767554B2 (en) | 2004-07-27 |
| JP2001002565A (ja) | 2001-01-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE311907T1 (de) | Anwendung von komplexen von kationischen liposomen und polydeoxyribonukleotiden wie arzneimitteln | |
| ES2054678T5 (es) | Conjugados estrella. | |
| DE69815075D1 (de) | Dimere kationische lipide auf dicystinbasis | |
| EE200200064A (et) | Arüülmetüülkarbonüülaminotiasooli derivaadid, nende valmistamine ja kasutamine vähivastaste toimeainetena | |
| WO2003015711A3 (en) | Combination motif immune stimulatory oligonucleotides with improved activity | |
| FR2781667B1 (fr) | Patch cosmetique, pharmaceutique, ou dermatologique | |
| CY1112361T1 (el) | Σκευασματα για αντικαρκινικη θεραπεια που περιεχουν εκτεϊνασκιδινη 743 | |
| DE50003116D1 (de) | Neuartige arzneimittelkompositionen auf der basis von tiotropiumbromid und salmeterol | |
| FR2870741B1 (fr) | Phase lamellaires hydratees ou liposomes, contenant une monoamine grasse ou un polymere cationique favorisant la penetration intercellulaire, et composition cosmetique ou pharmaceutique la contenant. | |
| DE60000992T2 (de) | Desinfizierende zusammensetzung auf basis von h2o2, säuren und metallionen | |
| ATE326536T1 (de) | Herstellung von biologisch aktiven molekülen | |
| DE60002526D1 (de) | Herstellung von Tricyclodecandicarbaldehyd, Pentacyclopentadecandicarbaldehyd und der entsprechenden Dimethanole | |
| ID30116A (id) | Turunan-turunan piridopiranoazepin, pembuatannya dan penggunaan terapinya | |
| EE200000037A (et) | Atsüülpiperasinüülpürimidiinide derivaadid, nende valmistamine ja kasutamine ravimitena | |
| DE69501530D1 (de) | Herstellung von trans-1,4-Polybutadien mit kontrolliertem Molekulargewicht | |
| WO1999013816A3 (en) | Liposomal camptothecin formulations | |
| DE59902006D1 (de) | Wirkstoffhaltige aromatische copolyester | |
| CA2361841A1 (en) | Mevinolin derivatives | |
| EP0891782A3 (de) | Medizinische Selbstklebefolie und Verfahren zu deren Herstellung | |
| BR9800349A (pt) | Preparação de catalisadores à base de antimonato de vanádio utilizando sn02.xhs20 | |
| TR24531A (tr) | Koku uyumlu bueyuek amin katyonik polimerli kisisel temizleme ueruenue | |
| DE59804442D1 (de) | Katalysatoren auf basis von fulven-metallkomplexen | |
| DK1011329T3 (da) | 7-Methylthiooxomethyl- og 7-methylthiodioxomethyl-paclitaxeler | |
| DE69427595D1 (de) | Antitumormittel auf basis von carboplatin und herstellung desselben | |
| ID28707A (id) | 1,2,4-trioksan tersubstitusi sebagai obat anti malaria dan metode pembuatannya |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1059092 Country of ref document: EP |